Padeliporfin

Padeliporfin (also known as Tookad) is a photosensitizing drug used to treat prostate cancer. It works by targeting the blood vessels in the prostate, leading to destruction of cancer cells without damaging the surrounding healthy tissue. Padeliporfin is administered intravenously and then activated by laser light, causing destruction of the cancer cells. It is used in combination with other treatments such as radiation therapy and hormone therapy.

Padeliporfin, sold under the brand name Tookad, is a medication used to treat a specific type of prostate cancer in adult men [1, 2]. Here's a breakdown of its key features:

Condition Treated:

• Padeliporfin is indicated for adults with previously untreated, unilateral, low-risk adenocarcinoma of the prostate [1]. This means it targets:
  • Only one side (unilateral) of the prostate
  • Slow-growing (low-risk) prostate cancer
  • A specific type of prostate cancer cells (adenocarcinoma)

How Does Padeliporfin Work?

• Padeliporfin belongs to a class of drugs called photosensitizers.
• It's used in a treatment modality called vascular-targeted photodynamic therapy (VTP) [2]. Here's the process:
  • Padeliporfin is injected into the bloodstream.
  • The drug accumulates in the prostate gland's blood vessels.
  • Afterwards, a laser light is shone on the targeted area of the prostate.
  • The laser light activates Padeliporfin, which damages nearby cancer cells.

Benefits of Padeliporfin VTP:

• This minimally invasive procedure offers an alternative to traditional treatments like surgery or radiation for some men with low-risk prostate cancer [3].
• It may potentially preserve sexual and urinary function compared to other therapies [2].

Important Considerations:

• Padeliporfin is only for carefully selected patients who meet specific criteria based on factors like age, life expectancy, and cancer characteristics [1].
• It can cause side effects, including urinary problems, sexual dysfunction, and pain in the genital area [2].
• Padeliporfin is a relatively new treatment, and long-term effects are still being studied [3].